Leerink Partners lifts Geron Corp. [GERN] price estimate. Who else is bullish?

Geron Corp. [NASDAQ: GERN] loss -3.94% or -0.17 points to close at $4.15 with a heavy trading volume of 7633190 shares.

The daily chart for GERN points out that the company has recorded 24.62% gains over the past six months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

If we look at the average trading volume of 9.00M shares, GERN reached to a volume of 7633190 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Geron Corp. [GERN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GERN shares is $7.31 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GERN stock is a recommendation set at 1.12. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Leerink Partners have made an estimate for Geron Corp. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on September 09, 2024. The new note on the price target was released on April 30, 2024, representing the official price target for Geron Corp. stock. Previously, the target price had yet another raise to $10, while TD Cowen analysts kept a Buy rating on GERN stock. On March 15, 2024, analysts increased their price target for GERN shares from 4 to 5.

The Average True Range (ATR) for Geron Corp. is set at 0.21, with the Price to Sales ratio for GERN stock in the period of the last 12 months amounting to 1826.00. The Price to Book ratio for the last quarter was 8.13, with the Price to Cash per share for the same quarter was set at 0.60.

Trading performance analysis for GERN stock

Geron Corp. [GERN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.59. With this latest performance, GERN shares dropped by -2.35% in over the last four-week period, additionally plugging by 24.62% over the last 6 months – not to mention a rise of 129.28% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GERN stock in for the last two-week period is set at 40.04, with the RSI for the last a single of trading hit 35.25, and the three-weeks RSI is set at 42.84 for Geron Corp. [GERN]. The present Moving Average for the last 50 days of trading for this stock 4.51, while it was recorded at 4.33 for the last single week of trading, and 3.55 for the last 200 days.

Geron Corp. [GERN]: A deeper dive into fundamental analysis

Geron Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.60 and a Current Ratio set at 3.61.

Geron Corp. [GERN]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GERN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Geron Corp. go to 5.00%.

An analysis of Institutional ownership at Geron Corp. [GERN]

There are presently around $77.98%, or 78.04%% of GERN stock, in the hands of institutional investors. The top three institutional holders of GERN stocks are: BLACKROCK INC. with ownership of 46.55 million shares, which is approximately 7.7138%. RA CAPITAL MANAGEMENT, L.P., holding 46.2 million shares of the stock with an approximate value of $$195.9 million in GERN stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$135.4 million in GERN stock with ownership which is approximately 5.2914%.